Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04158037Not ApplicableWithdrawn

Don't Go There: A Geospatial mHealth App for Gambling Disorder

Role: collaborator

NCT04064749Not ApplicableCompleted

Developing and Testing a Brief Intervention for Problem Gambling in Credit Counseling

Role: collaborator

NCT02772978Not ApplicableCompleted

Dopamine Responsivity in Gamblers

Role: collaborator

NCT01057862Phase 2Completed

Investigation of Naltrexone for Pathological Gambling

Role: collaborator

All 4 trials loaded